Ensayos clínicos

8.676 ensayos encontrados

CompletadoFase 3ClinicalTrials.gov

A Phase 3, Open-label, 52-week Study to Assess the Safety, Tolerability, and Efficacy of Rocatinlimab (AMG 451) in Adolescent Subjects Aged ≥ 12 to < 18 Years With Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Orbit)

INTERVENTIONALInicio: 30 de ene de 2023ID: NCT05633355

CompletadoClinicalTrials.gov

Self-directed Video Versus Instructor-based Neonatal Resuscitation Training of Novice Providers. A Controlled Blinded Randomized Non-inferiority Multicenter Study

INTERVENTIONALInicio: 1 de nov de 2015ID: NCT01847911

ReclutandoFase 4ClinicalTrials.gov

Non Randomized, Multicenter, Prospective Pediatric Hodgkin Lymphoma Treatment Trial Stratified According to Initial Risk Factors and Response to Chemotherapy, Reduced Cumulative Doses of Antineoplastic Agents and Radiotherapy.

INTERVENTIONALInicio: 6 de oct de 2017ID: NCT03500133

ReclutandoClinicalTrials.gov

Advanced Wireless Sensors for Neonatal Care in the Delivery Room: the AWARD Prospective Multicenter International Study

INTERVENTIONALInicio: 8 de abr de 2025ID: NCT06693817

CompletadoFase 3ClinicalTrials.gov

A Prospective Single Arm, Open-label, International, Multicenter Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Atazanavir (ATV) Powder Boosted With Ritonavir (RTV) With an Optimized NRTI Background Therapy, in Human Immunodeficiency Virus (HIV) Infected, Antiretroviral, Naive and Experienced Pediatric Subjects From 3 Months to Less Than 11 Years.(Pediatric Atazanavir International Clinical Evaluation: the PRINCE II Study)

INTERVENTIONALInicio: 27 de may de 2011ID: NCT01335698

CompletadoClinicalTrials.gov

Continuous Positive Airway Pressure Decreased Lung Collapse During General Anesthesia Induction in Pediatric Patients

INTERVENTIONALInicio: 1 de mar de 2018ID: NCT03461770

CompletadoFase 3ClinicalTrials.gov

A Randomized, Double-Blind, Efficacy and Safety Study of AR 14 (AZILSARTAN MEDOXOMIL) Treatment and Withdrawal, Followed by an Open-Label Extension, in Children 6 to Less Than 18 Years of Age With Hypertension

INTERVENTIONALInicio: 30 de mar de 2015ID: NCT02235909

CompletadoFase 4ClinicalTrials.gov

A Phase IV Open-label, Single-arm, Single-dose, Multicenter Study to Evaluate the saFEty, toLerability and effIcacy of Gene Replacement Therapy With intravenousOAV101(AVXS101) in Pediatric Patients From Latin America With Spinal Muscular Atrophy (SMA) - OFELIA

INTERVENTIONALInicio: 4 de nov de 2021ID: NCT05073133

CompletadoClinicalTrials.gov

A Multicenter, Long-Term, Active-Surveillance Study of Musculoskeletal Disorders That Occur After Initiating a Course of Levofloxacin (RWJ-25213-097) or Non-Fluoroquinolone Therapy for Acute Infectious Diseases in Children Who Were Enrolled in Phase 3 Clinical Trials Involving Levofloxacin Therapy

OBSERVATIONALInicio: 1 de ago de 2002ID: NCT00210639

CompletadoFase 3ClinicalTrials.gov

A LONG-TERM, OPEN-LABEL FOLLOW-UP STUDY OF TOFACITINIB FOR TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS (JIA)

INTERVENTIONALInicio: 18 de mar de 2013ID: NCT01500551

ReclutandoFase 3ClinicalTrials.gov

Interventional, Randomized, Double-blind, Parallel-group, Placebo-controlled Study to Evaluate the Efficacy and Safety of IV Eptinezumab in Adolescents (12-17 Years) for the Preventive Treatment of Chronic Migraine

INTERVENTIONALInicio: 30 de jun de 2021ID: NCT04965675

CompletadoClinicalTrials.gov

Congenital Syphilis at Third-level Pediatric Hospital. A Prospective Cohort With Retrospective Evaluation Study of the Last Three Decades.

OBSERVATIONALInicio: 1 de jul de 2019ID: NCT04137601

CompletadoFase 3ClinicalTrials.gov

A Double-Blind, Randomized, Multicenter, Placebo-controlled, In-Patient, Maximum 34 Day Study of Levetiracetam Oral Solution (20-50 mg/kg/Day) as Adjunctive Treatment of Refractory Partial Onset Seizures in Pediatric Epileptic Subjects Ranging in Age From 1 Month to Less Than 4 Years of Age

INTERVENTIONALInicio: 1 de oct de 2004ID: NCT00175890

DesconocidoFase 3ClinicalTrials.gov

Treatment of Asymptomatic Toxocariasis With Albendazole in Children. A Prospective, Randomized, Placebo-controlled Clinical Trial

INTERVENTIONALInicio: 1 de sept de 2008ID: NCT00755560

CompletadoFase 3ClinicalTrials.gov

A Phase IIIB, Randomized, Controlled, Observer-blind Study to Evaluate Safety and Immunogenicity of GSK's Meningococcal ABCWY Vaccine When Administered in Healthy Adolescents and Adults, Previously Primed With Meningococcal ACWY Vaccine

INTERVENTIONALInicio: 25 de ene de 2021ID: NCT04707391

CompletadoFase 3ClinicalTrials.gov

A Double-blind, Randomised, Placebo-controlled, Parallel Group Trial to Evaluate the Efficacy and Safety of Empagliflozin and Linagliptin Over 26 Weeks, With a Double-blind Active Treatment Safety Extension Period up to 52 Weeks, in Children and Adolescents With Type 2 Diabetes Mellitus

INTERVENTIONALInicio: 20 de mar de 2018ID: NCT03429543

Activo, no reclutaFase 3ClinicalTrials.gov

An Open-label, Single Arm, Multicenter Extension Study to Evaluate Long-term Safety and Tolerability of Inclisiran in Participants With Heterozygous or Homozygous Familial Hypercholesterolemia Who Have Completed the Adolescent ORION-16 or ORION-13 Studies (VICTORION-PEDS-OLE)

INTERVENTIONALInicio: 10 de feb de 2023ID: NCT05682378

CompletadoFase 4ClinicalTrials.gov

A Prospective Single Arm, Open-label, International, Multicenter Study to Evaluate the Safety of Atazanavir (ATV) Capsule Boosted With Ritonavir (RTV) With an Optimized NRTI Background Therapy, in HIV Infected, Antiretroviral Naive and Experienced Pediatric Subjects Greater Than or Equal to 6 Years to Less Than 18 Years

INTERVENTIONALInicio: 30 de nov de 2012ID: NCT01691794

CompletadoClinicalTrials.gov

Diet as Adjuvant Therapeutics in the Era of Biologics in Pediatric-onset Crohn's Disease.

INTERVENTIONALInicio: 14 de may de 2021ID: NCT05034458

CompletadoFase 2ClinicalTrials.gov

Phase 2 Study of Dextrose Injection for Sport-Limiting Osgood Schlatter Disease in Adolescents.

INTERVENTIONALInicio: 1 de ene de 2006ID: NCT01300754